FYN and Hepatic fibrosis: As our data indicated that Fyn can be considered as an attractive drug target for the liver fibrosis treatment, we evaluated the possible therapeutic effects on liver fibrosis of a clinically proven safe small molecule Fyn inhibitor Saracatinib.